½ÃÀ庸°í¼­
»óǰÄÚµå
1600743

ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : À¯Çü, »ç¾ç, ±â¼ú, Åõ¿© °æ·Î, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Disposable Syringes Market by Type (Conventional Syringes, Safety Syringes), Specification (10ml, 1ml, 20ml), Technology, Route of Adminstration, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀåÀº 2023³â¿¡ 167¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 181¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 8.81%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿© 2030³â¿¡´Â 302¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå¿¡´Â ´Ù¾çÇÑ ÀÇ·á ¹× ¼öÀÇÇÐ ¸ñÀûÀ» À§ÇØ ÀÏȸ¿ëÀ¸·Î ¼³°èµÈ ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ÁÖ»ç±â´Â ÀǾàǰ°ú ¹é½ÅÀ» Åõ¿©Çϰí Ç÷¾× »ùÇÃÀ» äÃëÇÏ´Â µ¥ ÇÊ¿äÇϸç À§»ýÀ» º¸ÀåÇϰí ÀÌÂ÷ ¿À¿°À» ¹æÁöÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. º´¿ø, Áø·á¼Ò, ÀçÅÃÄ¡·á, Á¦¾à ºÎ¹® µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Áß¿äÇÑ ÃÖÁ¾ »ç¿ë ºÎ¹®Àº ÀÇ·á Á¾»çÀÚ, ºó¹øÇÑ Áֻ簡 ÇÊ¿äÇÑ ¸¸¼º Áúȯ ȯÀÚ, ¹é½Å Á¢Á¾ ÇÁ·Î±×·¥ÀÔ´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå µ¿·ÂÀº ´ç´¢º´°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ¿¹¹æÁ¢Á¾ÀÌ ÇÊ¿äÇÑ ¼¼°è Àα¸ Áõ°¡, º´¿ø ³» °¨¿°¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¹«±Õ ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÁÖ»ç¹Ù´Ã ¾ÈÀü ±â¼ú, ģȯ°æ ¼ÒÀç °³¹ß µîÀÇ Çõ½ÅÀº Å« ºñÁî´Ï½º ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇϰíÀÚ ÇÏ´Â Á¦Á¶¾÷ü´Â ¾ÈÀü ±â´ÉÀ» °®Ãá ½º¸¶Æ® ÁÖ»ç±â ¹× ȯ°æÀûÀ¸·Î Áö¼Ó °¡´ÉÇÑ ¿É¼ÇÀ» ÅëÇÕÇÑ Á¦Ç° ¶óÀÎ È®Àå¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. ´ë·® °ø±Þ °è¾àÀ» À§ÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀåÀº ±ÔÁ¦ ¹®Á¦, °¡°Ý ¾Ð·Â, ÀÇ·á Æó±â¹°ÀÌ È¯°æ¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ¿ì·Á¿Í °°Àº Á¦¾à¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿øÀÚÀç °¡°Ý º¯µ¿°ú ´ëü ¾à¹° Àü´Þ ½Ã½ºÅÛÀÇ °¡¿ë¼º ¶ÇÇÑ °úÁ¦·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸ °³¹ßÀº ÇÃ¶ó½ºÆ½ »ç¿ë·®À» ÁÙÀÎ ÁÖ»ç±â »ý»ê°ú ¿ø°Ý ÀÇ·á ¼­ºñ½º¿Í °°Àº »õ·Î¿î ÀÇ·á ¼­ºñ½º ¸ðµ¨¿¡¼­ »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ã۱â À§ÇÑ IoT ±â¼ú ÅëÇÕ¿¡ ÁßÁ¡À» µÎ¾î¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ »ýºÐÇØ¼º ¹× ÀçȰ¿ëÀÌ °¡´ÉÇÑ ÁÖ»ç±â °³¹ß¿¡ ÁßÁ¡À» µÎ¾î ȯ°æ ¹®Á¦¸¦ ¿ÏÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ÇöÀç ¿ªµ¿ÀûÀÌ°í ¼ºÀåÇϰí ÀÖÁö¸¸, ±â¾÷Àº ±ÔÁ¦ »óȲÀ» ½ÅÁßÇÏ°Ô ÆÄ¾ÇÇϰí Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç¿¡ ÅõÀÚÇÏ¿© °æÀï ¿ìÀ§¸¦ À¯ÁöÇϰí ÀÏȸ¿ë ÁÖ»ç±âÀÇ Áö¼Ó °¡´ÉÇÑ ¼ºÀåÀ» °¡¼ÓÇϱâ À§ÇØ ³ë·ÂÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 167¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 181¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 302¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 8.81%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º Áúȯ ¹× ÀÇ·á °ü·Ã °¨¿° ±ÞÁõ
    • ÀÚ°¡ÁÖ»ç ÀåÄ¡ ¹× Àå½Ã°£ ÀÛ¿ëÇÏ´Â Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¿øÀÚÀç °¡°Ý º¯µ¿ ¹× Á¦Ç° ¸®ÄÝ Áõ°¡
  • ½ÃÀå ±âȸ
    • ¹ÙÀÌ¿À °³¹ß ¹× »ý»ê½Ã¼³ È®Àå
    • ÀÏȸ¿ë ÁÖ»ç±â ¿¬±¸ °³¹ß ¹× »õ·Î¿î Çõ½Å
  • ½ÃÀå °úÁ¦
    • ÁÖ»ç±âÀÇ ¾ÈÀüÇÑ ÆÄ±« ¹× Æó±â ¹®Á¦

Portre's Five Forces: ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀº º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ±¸ºÐÇÏ¿© »ç¿ëÀÚ°¡ Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ¾÷°è ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ ÇöÀç ½ÃÀå ȯ°æ¿¡ ´ëÇÑ »ó¼¼ÇÑ °ËÅä.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : À¯Çüº°

  • ±âÁ¸ ÁÖ»ç±â
  • ¾ÈÀü ÁÖ»ç±â
    • ºñ°Ý³³½Ä ¾ÈÀü ÁÖ»ç±â
    • °Ý³³½Ä ¾ÈÀü ÁÖ»ç±â

Á¦7Àå ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : »ç¾çº°

  • 10ml
  • 1ml
  • 20ml
  • 2ml
  • 30ml
  • 3ml
  • 50ml
  • 5ml

Á¦8Àå ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : ±â¼úº°

  • Screw Mouth Type
  • Single-use Insulin Syringe
  • Single-use Self-destructing Syringe
  • Three-piece Type
  • Two-piece Type

Á¦9Àå ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : Åõ¿© °æ·Îº°

  • ±ÙÀ°³» ÁÖ»ç
  • ¾×Á¦ Á¤¸Æ ÁÖ»ç
  • ÇÇÇÏ ÁÖ»ç

Á¦10Àå ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : ¿ëµµº°

  • ¿¹¹æ Á¢Á¾ ÁÖ»ç
  • Ä¡·á¿ë ÁÖ»ç

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®

±â¾÷ ¸®½ºÆ®

  • Jiangsu Shenli Medical Production Co., Ltd.
  • B. Braun SE
  • Terumo Corporation
  • Taizhou Sanxin Medical Technology Co., Ltd.
  • Weigao Group Medical Polymer Co., Ltd.
  • ICU Medical, Inc.
  • ALMO-Erzeugnisse Erwin Busch GmbH
  • Novo Nordisk A/S
  • GPE-Plast Engineering GmbH
  • Yangzhou Medline Industry Co., Ltd.
  • Shree Umiya Surgical Pvt. Ltd.
  • Henke Sass Wolf GmbH
  • Thermo Fisher Scientific Inc.
  • Hu-Friedy Mfg Co, LLC
  • UltiMed, Inc.
  • AdvaCare Pharma
  • Cole-Parmer Instrument Company, LLC
  • ISCON SURGICALS LTD.
  • Retractable Technologies, Inc.
  • Nipro Corporation
  • Hindustan Syringes & Medical Devices Ltd.
  • Baxter International, Inc.
  • Sulzer Ltd.
  • Becton, Dickinson and Company
  • Fresenius Kabi AG
  • Vita Needle Company
  • KD Medical GmbH Hospital Products
LSH

The Disposable Syringes Market was valued at USD 16.73 billion in 2023, expected to reach USD 18.19 billion in 2024, and is projected to grow at a CAGR of 8.81%, to USD 30.22 billion by 2030.

The disposable syringes market encompasses a range of products designed for one-time usage for various medical and veterinary purposes. These syringes are necessary to administer medications, vaccines, and collect blood samples, offering a critical tool in ensuring hygiene and preventing cross-contamination. They find applications across several areas, including hospitals, clinics, home care settings, and pharmaceutical sectors. The significant end-use segments are healthcare practitioners, chronic disease patients requiring frequent injections, and vaccination programs. Key growth drivers in this market include the increasing prevalence of chronic diseases like diabetes, a growing global population requiring immunizations, and heightened awareness about hospital-acquired infections, prompting higher demand for sterile medical equipment. Innovations such as needle safety technologies and the development of eco-friendly materials present substantial opportunities. Manufacturers aiming to capitalize on new opportunities should focus on expanding product lines to incorporate smart syringes with safety features and environmentally sustainable options. Strategic partnerships with healthcare providers for bulk supply contracts can also enhance market presence. However, the market faces limitations such as regulatory challenges, pricing pressures, and concerns over environmental impact due to medical waste. Additionally, the volatility in raw material prices and the availability of alternative drug delivery systems pose challenges. Research and development should focus on creating syringes with reduced plastic usage and integrating IoT technologies for better usability in emerging healthcare models like telemedicine services. An emphasis on developing biodegradable and recyclable syringes could also mitigate environmental concerns. The market is currently dynamic and poised for growth; however, businesses must navigate the regulatory landscape carefully and invest in innovative solutions to maintain competitive advantage and drive sustainable growth in disposable syringes.

KEY MARKET STATISTICS
Base Year [2023] USD 16.73 billion
Estimated Year [2024] USD 18.19 billion
Forecast Year [2030] USD 30.22 billion
CAGR (%) 8.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Disposable Syringes Market

The Disposable Syringes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in Prevalence of Chronic Diseases and Healthcare-Associated Infections
    • Increasing Demand for Self-Injection Devices & Long-Acting Formulations
  • Market Restraints
    • Fluctuating Prices of Raw Material and Increasing Product Recalls
  • Market Opportunities
    • Development of Bio-Based Disposable Syringes and Expansion of Production Facilities
    • Research and Development and New Innovations in Disposable Syringe
  • Market Challenges
    • Concerns Related to Safe Destruction and Disposal of Syringes

Porter's Five Forces: A Strategic Tool for Navigating the Disposable Syringes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Disposable Syringes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Disposable Syringes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Disposable Syringes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Disposable Syringes Market

A detailed market share analysis in the Disposable Syringes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Disposable Syringes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Disposable Syringes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Disposable Syringes Market, highlighting leading vendors and their innovative profiles. These include Jiangsu Shenli Medical Production Co., Ltd., B. Braun SE, Terumo Corporation, Taizhou Sanxin Medical Technology Co., Ltd., Weigao Group Medical Polymer Co., Ltd., ICU Medical, Inc., ALMO-Erzeugnisse Erwin Busch GmbH, Novo Nordisk A/S, GPE-Plast Engineering GmbH, Yangzhou Medline Industry Co., Ltd., Shree Umiya Surgical Pvt. Ltd., Henke Sass Wolf GmbH, Thermo Fisher Scientific Inc., Hu-Friedy Mfg Co, LLC, UltiMed, Inc., AdvaCare Pharma, Cole-Parmer Instrument Company, LLC, ISCON SURGICALS LTD., Retractable Technologies, Inc., Nipro Corporation, Hindustan Syringes & Medical Devices Ltd., Baxter International, Inc., Sulzer Ltd., Becton, Dickinson and Company, Fresenius Kabi AG, Vita Needle Company, and KD Medical GmbH Hospital Products.

Market Segmentation & Coverage

This research report categorizes the Disposable Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Conventional Syringes and Safety Syringes. The Safety Syringes is further studied across Non-Retractable Safety Syringes and Retractable Safety Syringes.
  • Based on Specification, market is studied across 10ml, 1ml, 20ml, 2ml, 30ml, 3ml, 50ml, and 5ml.
  • Based on Technology, market is studied across Screw Mouth Type, Single-use Insulin Syringe, Single-use Self-destructing Syringe, Three-piece Type, and Two-piece Type.
  • Based on Route of Adminstration, market is studied across Intramuscular Injection, Intravenous Injection of Liquid Medicine, and Subcutaneous Injection.
  • Based on Application, market is studied across Immunization Injections and Therapeutic Injections.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in Prevalence of Chronic Diseases and Healthcare-Associated Infections
      • 5.1.1.2. Increasing Demand for Self-Injection Devices & Long-Acting Formulations
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuating Prices of Raw Material and Increasing Product Recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of Bio-Based Disposable Syringes and Expansion of Production Facilities
      • 5.1.3.2. Research and Development and New Innovations in Disposable Syringe
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns Related to Safe Destruction and Disposal of Syringes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing usage of safety syringes due to regulatory environments that mandate their use to enhance occupational safety
    • 5.2.2. Specification: Rising preference for 30ml syringes for specific medical procedures that require the administration of large volumes
    • 5.2.3. Route of Administration: Expanding need for intravenous (IV) injections for the administration of liquid medication
    • 5.2.4. Application: Growing application of disposable syringes for immunization to ensure safety and efficacy in public health campaigns
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Disposable Syringes Market, by Type

  • 6.1. Introduction
  • 6.2. Conventional Syringes
  • 6.3. Safety Syringes
    • 6.3.1. Non-Retractable Safety Syringes
    • 6.3.2. Retractable Safety Syringes

7. Disposable Syringes Market, by Specification

  • 7.1. Introduction
  • 7.2. 10ml
  • 7.3. 1ml
  • 7.4. 20ml
  • 7.5. 2ml
  • 7.6. 30ml
  • 7.7. 3ml
  • 7.8. 50ml
  • 7.9. 5ml

8. Disposable Syringes Market, by Technology

  • 8.1. Introduction
  • 8.2. Screw Mouth Type
  • 8.3. Single-use Insulin Syringe
  • 8.4. Single-use Self-destructing Syringe
  • 8.5. Three-piece Type
  • 8.6. Two-piece Type

9. Disposable Syringes Market, by Route of Adminstration

  • 9.1. Introduction
  • 9.2. Intramuscular Injection
  • 9.3. Intravenous Injection of Liquid Medicine
  • 9.4. Subcutaneous Injection

10. Disposable Syringes Market, by Application

  • 10.1. Introduction
  • 10.2. Immunization Injections
  • 10.3. Therapeutic Injections

11. Americas Disposable Syringes Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Disposable Syringes Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Disposable Syringes Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Marubeni Acquires Stake in PT One-ject Indonesia, a Manufacturer of Medical Consumables
    • 14.3.2. Genixus Adds Manufacturing Facility for Syringe Production

Companies Mentioned

  • 1. Jiangsu Shenli Medical Production Co., Ltd.
  • 2. B. Braun SE
  • 3. Terumo Corporation
  • 4. Taizhou Sanxin Medical Technology Co., Ltd.
  • 5. Weigao Group Medical Polymer Co., Ltd.
  • 6. ICU Medical, Inc.
  • 7. ALMO-Erzeugnisse Erwin Busch GmbH
  • 8. Novo Nordisk A/S
  • 9. GPE-Plast Engineering GmbH
  • 10. Yangzhou Medline Industry Co., Ltd.
  • 11. Shree Umiya Surgical Pvt. Ltd.
  • 12. Henke Sass Wolf GmbH
  • 13. Thermo Fisher Scientific Inc.
  • 14. Hu-Friedy Mfg Co, LLC
  • 15. UltiMed, Inc.
  • 16. AdvaCare Pharma
  • 17. Cole-Parmer Instrument Company, LLC
  • 18. ISCON SURGICALS LTD.
  • 19. Retractable Technologies, Inc.
  • 20. Nipro Corporation
  • 21. Hindustan Syringes & Medical Devices Ltd.
  • 22. Baxter International, Inc.
  • 23. Sulzer Ltd.
  • 24. Becton, Dickinson and Company
  • 25. Fresenius Kabi AG
  • 26. Vita Needle Company
  • 27. KD Medical GmbH Hospital Products
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦